The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NeoACTIVATE arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable stage III melanoma.
 
Tina Hieken
Research Funding - Genentech/Roche (Inst); Skyline Diagnostics (Inst)
 
David Zahrieh
Employment - Ultragenyx Pharmaceuticals
Stock and Other Ownership Interests - Ultragenyx Pharmaceuticals
 
Thomas Flotte
Stock and Other Ownership Interests - Pramana
 
Roxana Dronca
Honoraria - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Natera; Replimune
Consulting or Advisory Role - BMS; BMS; BMS (Inst); Eisai; Elsevier; EMD Serono; Genzyme; Natera; Replimune
Research Funding - Alkermes (Inst); BMSi (Inst); BMSi (Inst); Emerson Collective (Inst); Merck Sharp & Dohme (Inst); Phosplatin Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); Spirita (Inst)
Patents, Royalties, Other Intellectual Property - Development of a Novel CAR-T Therapy to Tackle the Challenges of Immune Evasion
Travel, Accommodations, Expenses - BMSi; Replimune
Other Relationship - Elsevier
 
Evidio Domingo-Musibay
Research Funding - Immunocore (Inst); Iovance Biotherapeutics (Inst)
 
Garth Nelson
Employment - Mayo Clinic
 
Carrie Strand
No Relationships to Disclose
 
Lisa Kottschade
Consulting or Advisory Role - Immunocore
Research Funding - Thermo Diagnostics (Inst)
 
Heather Montane
No Relationships to Disclose
 
Mara Piltin
Honoraria - Kubtec medical imaging; OncLive/MJH Life Sciences (Inst)
Research Funding - Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Intuitive Surgical
 
Ruqin Chen
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I); Lilly
 
Robert McWilliams
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst)
 
James Jakub
Consulting or Advisory Role - Breathe BioMedical; Clarix Imaging Corporation
 
Samir Khariwala
No Relationships to Disclose
 
Arkadiusz Dudek
Leadership - IGF Oncology; TTC Oncology
Stock and Other Ownership Interests - IGF Oncology; Martell diagnostic; Squarex Pharma; TTC Oncology
Consulting or Advisory Role - HiberCell
Patents, Royalties, Other Intellectual Property - IGF Oncology
 
Jeffrey Johnson
Employment - CG Oncology (I)
Stock and Other Ownership Interests - CG Oncology (I)
 
Svetomir Markovic
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Nanoparticles (patents); Nanoparticles - immunoconjugates
 
Anastasios Dimou
Honoraria - Intellisphere; Intellisphere (Inst); Intellisphere (Inst); Roche/Genentech
Consulting or Advisory Role - Anheart Therapeutics; ChromaCode; Guardant Health (Inst); TP Therapeutics (Inst)
Research Funding - Anheart Therapeutics (Inst); AstraZeneca (Inst); Guardant Health; Merck; Novartis (Inst); Sorrento Therapeutics (Inst); Syntrix Biosystems (Inst)
Travel, Accommodations, Expenses - Guardant Health
Other Relationship - Rising Tide Foundation (Inst)
 
Kendall Tasche
No Relationships to Disclose
 
Matthew Block
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Marker, Inc. (Inst); Merck (Inst); nference (Inst); Perspective Therapeutics (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); TILT Biotherapeutics (Inst); Transgene (Inst); Viewpoint Molecular Targeting (Inst)
Patents, Royalties, Other Intellectual Property - Combinations of Dendritic Cell-Based Vaccines and Checkpoint Inhibitors, patent pending (Inst); Dendritic Cell-Based Vaccines and Uses Thereof, patent pending (Inst)
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting